FDAnews Drug Daily Bulletin

CARRINGTON REPORTS FIRST QUARTER RESULTS

May 5, 2006
A A

Carrington Laboratories, Inc., reported revenue of $7.5 million for the quarter ended March 31, 2006. While this is a decrease of 8.5% from last year's record-breaking first quarter, it was the second highest first quarter revenue in the Company's history. Reduced sales in bulk raw materials, due to a material decrease in purchases by a leading customer, were responsible for the bulk of the decline. This decrease was partially offset by an 18% increase in other revenues.
PR Newswire